AZN icon

AstraZeneca

1,372 hedge funds and large institutions have $45.1B invested in AstraZeneca in 2025 Q4 according to their latest regulatory filings, with 243 funds opening new positions, 490 increasing their positions, 411 reducing their positions, and 120 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1,372
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$591M
Puts
$420M
Net Calls
Net Calls Change

Top Buyers

1 +$420M
2 +$412M
3 +$327M
4
Citigroup
Citigroup
New York
+$204M
5
Barclays
Barclays
United Kingdom
+$180M

Top Sellers

1 -$924M
2 -$831M
3 -$550M
4
Primecap Management
Primecap Management
California
-$258M
5
Citadel Advisors
Citadel Advisors
Florida
-$241M
Name Holding Trade Value Shares
Change
Change in
Stake
BFS
1426
Bradley Foster & Sargent
Connecticut
PP
1427
Prospector Partners
Connecticut
BJL
1428
Brighton Jones LLC
Washington
CAM
1429
CenterStar Asset Management
Illinois
SM
1430
Stonegate Management
Illinois
CW
1431
CreativeOne Wealth
Kansas
SP
1432
Saranac Partners
LCGC
1433
Legacy Capital Group California
California
PVI
1434
Pine Valley Investments
New Jersey
BBW
1435
Blue Barn Wealth
Utah
GAG
1436
GM Advisory Group
New York
CPRC
1437
Consolidated Portfolio Review Corp
New York
NP
1438
NorthRock Partners
Minnesota
JG
1439
Jain Global
New York
APA
1440
Astoria Portfolio Advisors
New York
AP
1441
Advisors Preferred
Maryland
PFA
1442
Pure Financial Advisors
California
BAM
1443
Blueshift Asset Management
New Jersey
SA
1444
Sonoma Allocations
California
MFG
1445
MidWestOne Financial Group
Iowa
SB
1446
SIG Brokerage
New York
BFA
1447
Beaumont Financial Advisors
Massachusetts
NEPPG
1448
New England Professional Planning Group
Rhode Island
BCM
1449
Bayesian Capital Management
New York
AO
1450
Advisor OS
Illinois